Literature DB >> 21470287

Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure.

Wen-Sheng Yue1, Boon-Hor Chong, Xue-Hua Zhang, Song-Yan Liao, Man-Hong Jim, Annie W C Kung, Hung-Fat Tse, Chung-Wah Siu.   

Abstract

BACKGROUND: Heart failure occurs in 6% of hyperthyroid patients. Nonetheless, only half of those with hyperthyroidism-related heart failure have impaired left ventricular (LV) systolic function. Thus, diastolic dysfunction may play an important role in the pathogenesis. METHODS AND
RESULTS: We performed serial echocardiographic examinations in 70 consecutive patients with hyperthyroidism (39 ± 2 years, 47 women) to determine their diastolic function and repeated the examinations 6 months after achieving a euthyroid state. All patients had normal LV systolic function, but diastolic dysfunction was detected in 22 cases (mild: 3, moderate: 15 and severe: 4). The prevalence of diastolic dysfunction increased with age from 17·9 % in patients <40 years to 100% in those >60 years. Increasing age was the only independent predictor for diastolic dysfunction in hyperthyroid patients. After achievement of a euthyroid state, most patients (16/22, 72%) had completely normalized diastolic function: 100% of patients <40 years, 33·3 % of those ≥ 60 years. Further analyses revealed significant age-related differences in the cardiovascular response to hyperthyroidism. Among patients <40 years, hyperthyroidism resulted in a marked reduction in total peripheral vascular resistance, increased cardiac output and enhanced diastolic function as determined by E'. No such significant change in total peripheral vascular resistance or cardiac output was observed in hyperthyroid patients ≥ 40 years. In addition, hyperthyroidism was associated with reduced E', signifying diastolic dysfunction in older hyperthyroid patients.
CONCLUSION: Hyperthyroidism is associated with diastolic dysfunction, particularly in older patients. It is partly reversible following achievement of a euthyroid state.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21470287     DOI: 10.1111/j.1365-2265.2011.03981.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  16 in total

1.  Changes in cardiac function and structure in newly diagnosed Graves' disease. A conventional and 2D-speckle tracking echocardiography study.

Authors:  K Aroditis; M Pikilidou; E Vourvouri; L Hadjistavri; P Zebekakis; J Yovos; G Efthimiadis; H Karvounis
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-28       Impact factor: 2.357

Review 2.  Hyperthyroidism.

Authors:  Amanda R Doubleday; Rebecca S Sippel
Journal:  Gland Surg       Date:  2020-02

3.  Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The EPIPorto Study.

Authors:  João Sérgio Neves; Ricardo Fontes-Carvalho; Marta Borges-Canha; Ana Rita Leite; Sandra Martins; Ana Oliveira; João Tiago Guimarães; Davide Carvalho; Adelino Leite-Moreira; Ana Azevedo
Journal:  Eur Thyroid J       Date:  2020-07-08

4.  Unilateral pitting edema of the leg as a manifestation of Graves' disease: a case report.

Authors:  Vallo Volke; Svetlana Matjus
Journal:  J Med Case Rep       Date:  2012-08-30

5.  Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease.

Authors:  Pak Hei Chan; Wen Hua Li; Jo Jo Hai; Hung Fat Tse; Chung Wah Siu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease.

Authors:  Raphael C Anakwue; Basden J Onwubere; Vincent Ikeh; Benedict Anisiuba; Samuel Ike; Angel-Mary C Anakwue
Journal:  Ther Clin Risk Manag       Date:  2015-02-05       Impact factor: 2.423

7.  Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study.

Authors:  Frans Brandt; Marianne Thvilum; Dorthe Almind; Kaare Christensen; Anders Green; Laszlo Hegedüs; Thomas Heiberg Brix
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

8.  Determinants of thyrotoxic cardiomyopathy recovery.

Authors:  Lucia Oliveros-Ruiz; Maite Vallejo; L Fernando Diez Canseco; Manuel Cárdenas; J Antonio G Hermosillo
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

9.  Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology.

Authors:  Sibel Ertek; Arrigo F Cicero
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

10.  Thyrotoxic Atrial Fibrillation: Factors Associated with Persistence and Risk of Ischemic Stroke.

Authors:  Cheuk-Lik Wong; Ho-Kee Vicki Tam; Chun-Kit Vincent Fok; Pong-Kai Ellen Lam; Lai-Ming Fung
Journal:  J Thyroid Res       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.